Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Thoman

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1980
Regulation of the immune response. II. Characterization of the cell population(s) involved in the Fc fragment-induced adjuvant effectE L Morgan, M L Thoman, S M Walker, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1985
Human C3a-mediated suppression of the immune response. I. Suppression of murine in vitro antibody responses occurs through the generation of nonspecific Lyt-2+ suppressor T cellE L Morgan, M L Thoman, W O Weigle, et al.
The Journal of Experimental Medicine|July 1, 1980
Regulation of the immune response. I. The potentiation of in vivo and in vitro immune responses by Fc fragmentsE L Morgan, S M Walker, M L Thoman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1983
Anaphylatoxin-mediated regulation of the immune response. II. C5a-mediated enhancement of human humoral and T cell-mediated immune responsesE L Morgan, M L Thoman, W O Weigle, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
T cell differentiation and functional maturation in aging miceM L Thoman, D N Ernst, M V Hobbs, et al.
Immunology Letters|January 1, 1985
Bioactive complement fragments in immunoregulationE L Morgan, M L Thoman, P D Hoeprich, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1987
Identification of a lymphocyte-activating pentapeptide sequence in the Fc region of human IgG1M V Hobbs, E L Morgan, R A Houghten, et al.
Clinical Immunology and Immunopathology|October 1, 1985
Human C3a-mediated suppression of the immune response. II. Suppression of human in vitro polyclonal antibody responses occurs through the generation of nonspecific OKT8+ suppressor T cellsE L Morgan, M L Thoman, M V Hobbs, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1984
C3d-K, a kallikrein cleavage fragment of iC3b is a potent inhibitor of cellular proliferationM L Thoman, J L Meuth, E L Morgan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1997
Anti-human kappa opioid receptor antibodies: characterization of site-directed neutralizing antibodies specific for a peptide kappa R(33-52) derived from the predicted amino terminal region of the human kappa receptorR R Buchner, S M Vogen, W Fischer, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1980
Regulation of the immune response. II. Characterization of the cell population(s) involved in the Fc fragment-induced adjuvant effectE L Morgan, M L Thoman, S M Walker, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1985
Human C3a-mediated suppression of the immune response. I. Suppression of murine in vitro antibody responses occurs through the generation of nonspecific Lyt-2+ suppressor T cellE L Morgan, M L Thoman, W O Weigle, et al.
The Journal of Experimental Medicine|July 1, 1980
Regulation of the immune response. I. The potentiation of in vivo and in vitro immune responses by Fc fragmentsE L Morgan, S M Walker, M L Thoman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1983
Anaphylatoxin-mediated regulation of the immune response. II. C5a-mediated enhancement of human humoral and T cell-mediated immune responsesE L Morgan, M L Thoman, W O Weigle, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
T cell differentiation and functional maturation in aging miceM L Thoman, D N Ernst, M V Hobbs, et al.
Immunology Letters|January 1, 1985
Bioactive complement fragments in immunoregulationE L Morgan, M L Thoman, P D Hoeprich, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1987
Identification of a lymphocyte-activating pentapeptide sequence in the Fc region of human IgG1M V Hobbs, E L Morgan, R A Houghten, et al.
Clinical Immunology and Immunopathology|October 1, 1985
Human C3a-mediated suppression of the immune response. II. Suppression of human in vitro polyclonal antibody responses occurs through the generation of nonspecific OKT8+ suppressor T cellsE L Morgan, M L Thoman, M V Hobbs, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1984
C3d-K, a kallikrein cleavage fragment of iC3b is a potent inhibitor of cellular proliferationM L Thoman, J L Meuth, E L Morgan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1997
Anti-human kappa opioid receptor antibodies: characterization of site-directed neutralizing antibodies specific for a peptide kappa R(33-52) derived from the predicted amino terminal region of the human kappa receptorR R Buchner, S M Vogen, W Fischer, et al.
Pageof 5